Population pharmacokinetics of inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia and non-Hodgkin lymphoma May GarrettAna Ruiz-GarciaJoseph Boni Original Paper Open access 11 March 2019 Pages: 211 - 222
Challenge model of TNFα turnover at varying LPS and drug provocations Felix HeldEdmund HoppeJohan Gabrielsson Original Paper Open access 18 February 2019 Pages: 223 - 240
Development of visual predictive checks accounting for multimodal parameter distributions in mixture models Usman ArshadEstelle ChasseloupMats O. Karlsson Original Paper Open access 09 April 2019 Pages: 241 - 250
Population pharmacokinetics and pharmacodynamics of piperacillin in critically ill patients during the early phase of sepsis Waroonrat SukarnjanasetSutep JaruratanasirikulThitima Wattanavijitkul Original Paper 08 April 2019 Pages: 251 - 261
Pitfalls of using numerical predictive checks for population physiologically-based pharmacokinetic model evaluation Anil R. MaharajHuali WuMichael Cohen-Wolkowiez Original Paper 23 April 2019 Pages: 263 - 272
Operating characteristics of stepwise covariate selection in pharmacometric modeling Malidi AhamadiAnna LargajolliFerdous Gheyas Original Paper 24 April 2019 Pages: 273 - 285
Guiding dose selection of monoclonal antibodies using a new parameter (AFTIR) for characterizing ligand binding systems Sameed AhmedMiandra EllisAndrew M. Stein Original Paper 29 April 2019 Pages: 287 - 304
Two-pore physiologically based pharmacokinetic model with de novo derived parameters for predicting plasma PK of different size protein therapeutics Zhe LiDhaval K. Shah Original Paper 26 April 2019 Pages: 305 - 318